Zobrazeno 1 - 10
of 76
pro vyhledávání: '"Ray D. Page"'
Autor:
Vassiliki A. Papadimitrakopoulou, Richard B. Lanman, Justin I. Odegaard, Daniel Dix, Miguel A. Villalona-Calero, Karen L. Reckamp, Stephen G. Divers, Davey B. Daniel, Victoria M. Raymond, Ray D. Page, Natasha B. Leighl
Supplementary Table 1: Detailed assessment of each of the 282 patients. For each of the 282 patients, genomic testing outcome for each modality and each of the eight genomic biomarkers is outlined, as well as KRAS and tissue assessed PD-L1 expression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4712b23d27b0a31df6948681435e10a9
https://doi.org/10.1158/1078-0432.22472013.v1
https://doi.org/10.1158/1078-0432.22472013.v1
Autor:
Vassiliki A. Papadimitrakopoulou, Richard B. Lanman, Justin I. Odegaard, Daniel Dix, Miguel A. Villalona-Calero, Karen L. Reckamp, Stephen G. Divers, Davey B. Daniel, Victoria M. Raymond, Ray D. Page, Natasha B. Leighl
Supplementary Table Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::165bed7fa3af99fe213112e50a7b2c8f
https://doi.org/10.1158/1078-0432.22472010
https://doi.org/10.1158/1078-0432.22472010
Autor:
Vassiliki A. Papadimitrakopoulou, Richard B. Lanman, Justin I. Odegaard, Daniel Dix, Miguel A. Villalona-Calero, Karen L. Reckamp, Stephen G. Divers, Davey B. Daniel, Victoria M. Raymond, Ray D. Page, Natasha B. Leighl
Purpose:Complete and timely tissue genotyping is challenging, leading to significant numbers of patients with newly diagnosed metastatic non–small cell lung cancer (mNSCLC) being undergenotyped for all eight genomic biomarkers recommended by profes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b61681bc5a7d80341388c4b6bb86e46a
https://doi.org/10.1158/1078-0432.c.6528081.v1
https://doi.org/10.1158/1078-0432.c.6528081.v1
Autor:
Todd A. Pickard, Sibel Blau, Erin B. Kennedy, Ashley L Sumrall, Kerin B. Adelson, Ray D. Page, Trevor J. Royce, Natalie R. Dickson, David Gill, Nicole Laferriere, Ana Maria Lopez, Debra A. Patt, Robin Zon, Terry Purdom, Therese M. Mulvey
Publikováno v:
JCO Oncology Practice. 17:546-564
PURPOSE To provide standards and practice recommendations specific to telehealth in oncology. METHODS A systematic review of the literature on telehealth in oncology was performed, including the use of technologies and telecommunications systems, and
Publikováno v:
JCO Oncology Practice. 17:e448-e453
Oncology drug repository programs allow patients to donate oral chemotherapy that can be redispensed to patients in need and could ultimately reduce drug waste. Medically integrated pharmacies can serve as a platform for drug repository programs beca
Autor:
Alexander L. Chin, Deborah Y. Kamin, Ray D. Page, Stephen Grubbs, Mary Rappaport, Sybil Green, Jeffery C. Ward, Brian Bourbeau
Publikováno v:
JCO Oncology Practice. 16:263-269
The past decade has seen considerable innovation in the delivery of care and payment in oncology. Key initiatives have included the development of oncology medical home care delivery standards, the Medicare Oncology Care Model, and multiple commercia
Autor:
Kirollos Samir Hanna, Elana Plotkin, Ray D. Page, Lisa A. Kottschade, Billie Baldwin, Martha Raymond, Mary Anderson, Kathy Oubre, Laura S. Wood, Joseph Kim, Leigh Boehmer
Publikováno v:
Journal of Clinical Oncology. 40:52-52
52 Background: When combination medical therapy incorporates both IV and oral anti-cancer agents, patients may experience compound side effects and face challenges with treatment adherence. To assess how community cancer programs may improve care coo
Autor:
Piyush Srivastava, Rebecca Spence, Ray D. Page, Arif H. Kamal, Fay J. Hlubocky, Molly M. McGinnis, Colleen M. Gallagher, Tait D. Shanafelt, Anthony L. Back, John M. Burke, Judith A. Paice, Daniel C. McFarland
Publikováno v:
JCO oncology practice. 17(7)
INTRODUCTION: The COVID-19 pandemic is an unprecedented global crisis profoundly affecting oncology care delivery. PURPOSE: This study will describe the occupational and personal consequences of the COVID-19 pandemic on oncologist well-being and pati
Autor:
Deborah A. Boyle, Eric Daniel Tetzlaff, Piyush Srivastava, Anthony L. Back, Denise M. Dudzinski, Tait D. Shanafelt, Arif H. Kamal, Monica Chatwal, Maria M Gonzalez, Daniel C. McFarland, Ted A. James, Fay J. Hlubocky, Judith A. Paice, Joel N. Saltzman, Ray D. Page, John M. Burke, Laurie J. Lyckholm, Colleen M. Gallagher, Christopher R. Friese
Publikováno v:
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 41
Optimizing the well-being of the oncology clinician has never been more important. Well-being is a critical priority for the cancer organization because burnout adversely impacts the quality of care, patient satisfaction, the workforce, and overall p
Autor:
Miguel A. Villalona-Calero, Natasha B. Leighl, Leylah Drusbosky, Stephen G. Divers, Hiba I. Dada, Karen L. Reckamp, Richard B. Lanman, Davey B. Daniel, Daniel Dix, Vassiliki A. Papadimitrakopoulou, Victoria M. Raymond, Justin I. Odegaard, Ray D. Page
Publikováno v:
Clinical lung cancer. 23(1)
Background Somatic genomic testing is recommended by numerous expert guidelines to inform targeted therapy treatment for patients with advanced nonsquamous non-small cell lung cancer (aNSCLC). The NILE study was a prospective observational study that